Beijing Remebot Technology Co., Ltd. is a leader in the development, production, sales, and operation of innovative medical robots for surgical excellence. Founded in 2010, Remebot is at the forefront of the AI, Health Care, and Robotics industries. The company recently secured a CNY430.00M Series D investment on 16 December 2020. This substantial investment came from a prestigious group of backers, including CITIC Capital, Matrix Partners China, 北京新鼎荣盛资本管理有限公司, Chord Capital, China Securities Co., Ltd., Hexin Capital, Beijing Zhongguancun Longmen investment, Zhejiang Zhongke Heyin Venture Capital, and Jingwei Investments. Remebot has specialized in the development, production, sales, and operation of medical robots to significantly enhance surgical procedures, exemplifying their commitment to innovation and excellence.
No recent news or press coverage available for Beijing Remebot Technology Co., Ltd..